Feature

ASH urges lawmakers to keep opioids accessible


 


But Diane E. Meier, MD, director of the Center to Advance Palliative Care in New York, said the most current data suggest the risk of addiction and substance use disorder among medically-ill patients taking opioids is less than 10%. “That means that 90% of patients with a serious medical illness can safely take opioids for the relief of pain that is causing functional disorder,” she said.

Policymakers should not conflate the use and prescription of opioids with cases of misuse and abuse, Dr. Alvarnas said. Some patients will require a higher dose of opioids depending on their age or number of pain episodes, or because of their body’s physiological response.

Dr. Ifeyinwa (Ify) Osunkwo, a sickle cell disease specialist at Levine Cancer Institute in Charlotte, N.C.

Dr. Ifeyinwa (Ify) Osunkwo

“No matter what the medicine is, they’re going to require a higher dose for future episodes of pain because of repeated exposure,” said Ifeyinwa Osunkwo, MD, MPH, a sickle cell disease specialist at Levine Cancer Institute in Charlotte, N.C., and a member of the Hematology News editorial advisory board.

Some policies, such as a prior authorization, create “artificial barriers and delays in getting access to medication” for these patients, Dr. Alvarnas said. “When you create a far more arduous prior [authorization] process or limit prescriptions ... if someone has a severe blood disorder or a bone cancer, then what you’re doing is setting up a system that will fail those patients on a regular basis,” he said.

Pages

Recommended Reading

Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Hematology and Oncology
Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
CMS proposes inpatient payment model for CAR T therapies
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Hematology and Oncology
AMA: Opioid prescriptions down since 2013
MDedge Hematology and Oncology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Hematology and Oncology